Quarterly report pursuant to Section 13 or 15(d)

Investments

v3.5.0.2
Investments
9 Months Ended
Sep. 30, 2016
Investments [Abstracts]  
Investments
INVESTMENTS
Investments in debt and marketable securities, other than investments accounted for under the equity method, are classified as trading, available-for-sale or held-to-maturity. Our marketable equity investments are classified as either trading or available-for-sale with their cost basis determined by the specific identification method. Our investments in debt securities are carried at either amortized cost or fair value. Investments in debt securities that the Company has the positive intent and ability to hold to maturity are carried at amortized cost and classified as held-to-maturity. Investments in debt securities that are not classified as held-to-maturity are carried at fair value and classified as either trading or available-for-sale. Realized and unrealized gains and losses on trading securities and realized gains and losses on available-for-sale securities are included in net income. Unrealized gains and losses, net of deferred taxes, on available-for-sale securities are included in our consolidated balance sheets as a component of AOCI, except for the change in fair value attributable to the currency risk being hedged. Refer to Note 5 for additional information related to the Company's fair value hedges of available-for-sale securities.
Trading Securities
As of September 30, 2016 and December 31, 2015, our trading securities had a fair value of $379 million and $322 million, respectively, and consisted primarily of equity securities. The Company had net unrealized gains on trading securities of $37 million and $19 million as of September 30, 2016 and December 31, 2015, respectively.
The Company's trading securities were included in the following line items in our condensed consolidated balance sheets (in millions):
 
September 30, 2016

December 31, 2015

Marketable securities
$
277

$
229

Other assets
102

93

Total
$
379

$
322


Available-for-Sale and Held-to-Maturity Securities
As of September 30, 2016 and December 31, 2015, the Company did not have any held-to-maturity securities. As of September 30, 2016, available-for-sale securities consisted of the following (in millions):
 
 
Gross Unrealized
 
Estimated

 
Cost

Gains

Losses

 
Fair Value

Available-for-sale securities:1
 
 
 
 
 
Equity securities
$
1,266

$
484

$
(35
)
 
$
1,715

Debt securities
4,792

113

(15
)
 
4,890

Total
$
6,058

$
597

$
(50
)
 
$
6,605


1 Refer to Note 14 for additional information related to the estimated fair value.
As of December 31, 2015, available-for-sale securities consisted of the following (in millions):
 
 
Gross Unrealized
 
Estimated

 
Cost

Gains

Losses

 
Fair Value

Available-for-sale securities:1
 
 
 
 
 
Equity securities
$
3,573

$
485

$
(84
)
 
$
3,974

Debt securities
4,593

64

(25
)
 
4,632

Total
$
8,166

$
549

$
(109
)
 
$
8,606

1 Refer to Note 14 for additional information related to the estimated fair value.
The sale and/or maturity of available-for-sale securities resulted in the following realized activity (in millions):
 
Three Months Ended
 
Nine Months Ended
 
September 30, 2016

October 2, 2015

 
September 30, 2016

October 2, 2015

Gross gains
$
21

$
44

 
$
131

$
85

Gross losses
(6
)
(15
)
 
(42
)
(27
)
Proceeds
2,072

1,016

 
8,889

3,320


As of September 30, 2016 and December 31, 2015, the Company had investments classified as available-for-sale in which our cost basis exceeded the fair value of our investment. Management assessed each of the available-for-sale securities that were in a gross unrealized loss position on an individual basis to determine if the decline in fair value was other than temporary. Management's assessment as to the nature of a decline in fair value is based on, among other things, the length of time and the extent to which the market value has been less than our cost basis; the financial condition and near-term prospects of the issuer; and our intent and ability to retain the investment for a period of time sufficient to allow for any anticipated recovery in market value. As a result of these assessments, management determined that the decline in fair value of these investments was not other than temporary and did not record any impairment charges.
The Company uses two of its insurance captives to reinsure group annuity insurance contracts that cover the pension obligations of certain of our European and Canadian pension plans. In accordance with local insurance regulations, our insurance captives are required to meet and maintain minimum solvency capital requirements. The Company elected to invest its solvency capital in a portfolio of available-for-sale securities, which are classified in the line item other assets in our condensed consolidated balance sheets because the assets are not available to satisfy our current obligations. As of September 30, 2016 and December 31, 2015, the Company's available-for-sale securities included solvency capital funds of $976 million and $804 million, respectively.
The Company's available-for-sale securities were included in the following line items in our condensed consolidated balance sheets (in millions):
 
September 30,
2016

December 31,
2015

Cash and cash equivalents
$
1,635

$
361

Marketable securities
2,880

4,040

Other investments
967

3,280

Other assets
1,123

925

Total
$
6,605

$
8,606


The contractual maturities of these available-for-sale securities as of September 30, 2016 were as follows (in millions):
 
Cost

Estimated Fair Value

Within 1 year
$
1,994

$
1,994

After 1 year through 5 years
2,277

2,336

After 5 years through 10 years
186

204

After 10 years
335

356

Equity securities
1,266

1,715

Total
$
6,058

$
6,605


The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.
Cost Method Investments
Cost method investments are initially recorded at cost, and we record dividend income when applicable dividends are declared. Cost method investments are reported as other investments in our condensed consolidated balance sheets, and dividend income from cost method investments is reported in other income (loss) — net in our condensed consolidated statements of income. We review all of our cost method investments quarterly to determine if impairment indicators are present; however, we are not required to determine the fair value of these investments unless impairment indicators exist. When impairment indicators exist, we generally use discounted cash flow analyses to determine the fair value. We estimate that the fair values of our cost method investments approximated or exceeded their carrying values as of September 30, 2016 and December 31, 2015. Our cost method investments had carrying values of $143 million and $190 million as of September 30, 2016 and December 31, 2015, respectively.